Cargando…
Comparing the Effectiveness of Propranolol versus Atenolol in Inducing Clinical Clearance in the Treatment of Infantile Haemangioma: A Randomised Controlled Trial
BACKGROUND: Despite the excellent clinical efficacy of oral propranolol in the management of infantile haemangiomas (IHs), there is a need to further evaluate other beta blockers that may be equally efficacious but result in lesser adverse effects. We compared the efficacy and short-term safety of a...
Autores principales: | Ashraf, Raihan, Mahajan, Rahul, Malik, Muneer A., Handa, Sanjeev, Sinha, Anindita, De, Dipankar, Sachdeva, Naresh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238967/ https://www.ncbi.nlm.nih.gov/pubmed/37275818 http://dx.doi.org/10.4103/ijd.ijd_867_22 |
Ejemplares similares
-
Pleuri-Segmental Ipsilateral Nonsyndromic Infantile Hemangioma Responding Favorably to Oral Propranolol
por: Ashraf, Raihan, et al.
Publicado: (2020) -
Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma
por: HERMANS, Mireille M., et al.
Publicado: (2022) -
Atenolol vs. propranolol for the treatment of infantile haemangiomas: A systematic review and meta-analysis
por: Liu, Zhuang, et al.
Publicado: (2020) -
Cost-effectiveness of atenolol compared to propranolol as first-line treatment of infantile haemangioma: A pilot study
por: Wilson, Sasha, et al.
Publicado: (2022) -
A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas
por: Zhao, Ze-Liang, et al.
Publicado: (2021)